AAAAAA
Results:
1-13
|
Results: 13
Authors:
Gerstein, HC
Mann, JFE
Yi, QL
Zinman, B
Dinneen, SF
Hoogwerf, B
Halle, JP
Young, J
Rashkow, A
Joyce, C
Nawaz, S
Yusuf, S
Citation: Hc. Gerstein et al., Albuminuria and risk of cardiovascular events, death, and heart failure indiabetic and nondiabetic individuals, J AM MED A, 286(4), 2001, pp. 421-426
Authors:
Thorey, IS
Roth, J
Regenbogen, J
Halle, JP
Bittner, M
Vogl, T
Kaesler, S
Bugnon, P
Reitmaier, B
Durka, S
Graf, A
Wockner, M
Rieger, N
Konstantinow, A
Wolf, E
Goppelt, A
Werner, S
Citation: Is. Thorey et al., The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes, J BIOL CHEM, 276(38), 2001, pp. 35818-35825
Authors:
Malone, JK
Yang, H
Woodworth, JR
Huang, J
Campaigne, BN
Halle, JP
Yale, JF
Grossman, LD
Citation: Jk. Malone et al., Humalog (R) Mix25 (TM) offers better mealtime glycemic control in patientswith type 1 or type 2 diabetes, DIABETE MET, 26(6), 2000, pp. 481-487
Authors:
Gerstein, HC
Mann, JFE
Pogue, J
Dinneen, SF
Halle, JP
Hoogwerf, B
Joyce, C
Rashkow, A
Young, J
Zinman, B
Yusuf, S
Citation: Hc. Gerstein et al., Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study, DIABET CARE, 23, 2000, pp. B35-B39
Authors:
Raskin, P
Klaff, L
Bergenstal, R
Halle, JP
Donley, D
Mecca, T
Citation: P. Raskin et al., A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes, DIABET CARE, 23(11), 2000, pp. 1666-1671
Authors:
Malone, JK
Woodworth, JR
Arora, V
Yang, HC
Campaigne, BN
Halle, JP
Yale, JF
Grossman, LD
Citation: Jk. Malone et al., Improved postprandial glycemic control with Humalog (R) Mix75/25 (TM) after a standard test meal in patients with type 2 diabetes mellitus, CLIN THER, 22(2), 2000, pp. 222-230
Authors:
Lacourciere, Y
Belanger, A
Godin, C
Halle, JP
Ross, S
Wright, N
Marion, J
Citation: Y. Lacourciere et al., Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy, KIDNEY INT, 58(2), 2000, pp. 762-769
Authors:
Robitaille, R
Desbiens, K
Henley, N
Halle, JP
Citation: R. Robitaille et al., Time course of transforming growth factor-beta(1) (TGF-beta(1)) mRNA expression in the host reaction to alginate-poly-L-lysine microcapsules following implantations into rat epididymal fat pads, J BIOMED MR, 52(1), 2000, pp. 18-23
Authors:
Robitaille, R
Leblond, FA
Bourgeois, Y
Henley, N
Loignon, M
Halle, JP
Citation: R. Robitaille et al., Studies on small (< 350 mu m) alginate-poly-L-lysine microcapsules. V. Determination of carbohydrate and protein permeation through microcapsules by reverse-size exclusion chromatography, J BIOMED MR, 50(3), 2000, pp. 420-427
Authors:
Leblond, FA
Simard, G
Henley, N
Rocheleau, B
Huet, PM
Halle, JP
Citation: Fa. Leblond et al., Studies on smaller (similar to 315 mu M) microcapsules: IV. Feasibility and safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules, CELL TRANSP, 8(3), 1999, pp. 327-337
Authors:
Haus-Seuffert, P
Halle, JP
Sanner, S
Meisterernst, M
Citation: P. Haus-seuffert et al., Conserved cAMP responsive element and core promoter complex are critical for specificity of the distal T-cell receptor beta chain enhancer for its native promoter, GENE, 236(2), 1999, pp. 209-219
Authors:
Robitaille, R
Leblond, FA
Henley, N
Prud'homme, GJ
Drobetsky, E
Halle, JP
Citation: R. Robitaille et al., Alginate-poly-L-lysine microcapsule biocompatibility: A novel RT-PCR method for cytokine gene expression analysis in pericapsular infiltrates, J BIOMED MR, 45(3), 1999, pp. 223-230
Authors:
Robitaille, R
Pariseau, JF
Leblond, FA
Lamoureux, M
Lepage, Y
Halle, JP
Citation: R. Robitaille et al., Studies on small (< 350 mu m) alginate-poly-L-lysine microcapsules. III. Biocompatibility of smaller versus standard microcapsules, J BIOMED MR, 44(1), 1999, pp. 116-120
Risultati:
1-13
|